𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia

✍ Scribed by N. Tsukamoto; M. Karasawa; T. Maehara; K. Okamoto; H. Sakai; T. Naruse; K. Morita; J. Tsuchiya; M. Omine

Book ID
104857541
Publisher
Springer
Year
1996
Tongue
English
Weight
523 KB
Volume
72
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Polymorphism of the human HA-RAS oncogen
Polymorphism of the human HA-RAS oncogene locus in chronic lymphocytic and chronic myelogenous leukemia
✍ Dr W. U. Knauf; A. D. Ho πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

## Abstract DNA from white blood cells from healthy controls demonstrates a restriction fragment length polymorphism (RFLP) of the Ha‐ras oncogene locus after cleavage with the restriction enzymes BamH I or MspI plus HpaII, representing frequent and rare alleles. We have studied the RFLP of 15 pati

The significance of myelosuppression dur
The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase
✍ Thomas B. Sneed; Hagop M. Kantarjian; Moshe Talpaz; Susan O'Brien; Mary Beth Rio πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Imatinib mesylate induces high rates of hematologic and cytogenetic response in patients with chronic myelogenous leukemia (CML). During therapy with imatinib, up to 45% of patients with CML reportedly experience myelosuppression β‰₯ Grade 3, requiring interruption of thera